Cite
MLA Citation
Martin Faehling et al.. “Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP).” Lung cancer, vol. 150, 2020, pp. 114–122. http://access.bl.uk/ark:/81055/vdc_100115294051.0x00004a